American Journal of Nephrology · 2010 · 17 citations · 25 references
MedicineEndocrinologyPharmacologyRenal PathologyRenal PathophysiologyRenal PharmacotherapyDiabetes MellitusDiabetic NephropathyGlomerular PathophysiologyRenal DiseaseRenal PharmacologyRenal PhysiologyBlood PressureDiabetic GlomerulosclerosisDiabetic Kidney Disease ProgressionInflammation In Renal InjuryNephrin SignalingPeroxisome Proliferator-activated Receptor SignalingPeroxisome Proliferator-activated ReceptorsRenal Interstitial Inflammation
BACKGROUNDS/AIMS: Renal inflammation and nephrin downregulation contribute to albuminuria in diabetes. We studied, in streptozotocin-induced diabetic rats, the effect of rosiglitazone (RSG), a peroxisome proliferator-activated receptor-γ agonist, on renal macrophage infiltration, MCP1, and nephrin expression in relation to albuminuria. METHODS: We investigated control and diabetic rats treated or untreated with RSG. Animals were sacrificed at 1, 3, and 9 months. Renal MCP1 and nephrin expression were studied by immunoblotting, renal macrophage infiltration by immunohistochemistry, and albuminuria by ELISA. Electron microscopy was used to assess glomerular ultrastructural morphology. In vitro experiments were conducted in isolated cultured rat glomeruli. RESULTS: Glycaemic control was similar in diabetic rats treated and untreated with RSG, and blood pressure was comparable in all groups. RSG prevented diabetes-induced albuminuria at 9 months, and renal macrophage infiltration and MCP1 upregulation at 3 and 9 months. Diabetes-mediated nephrin downregulation was abolished by RSG. Diabetes-induced glomerulosclerosis, glomerular basement membrane thickening, and foot process fusion were not affected by RSG. In isolated glomeruli, MCP1 directly induced nephrin downregulation and this was prevented by RSG. RSG had no effect on nephrin expression. CONCLUSION: RSG prevents albuminuria and nephrin downregulation in experimental diabetes independently of glycaemic and blood pressure control. This effect likely occurs via correction of diabetes-induced inflammatory processes.
25
Ranjan Mukherjee, Lily Jow, Glenn Croston et al. · Journal of Biological Chemistry · 1997 · 422 citations · Full text
Medicine, Cell Biology, Pharmacology +13
Greg H. Tesch, Stefanie Maifert, Andreas Schwarting et al. · The Journal of Experimental Medicine · 1999 · 302 citations · Full text
Life Sciences, Immunology, Pathology +17